248 related articles for article (PubMed ID: 35625885)
1. Use of Urinary Cytokine and Chemokine Levels for Identifying Bladder Conditions and Predicting Treatment Outcomes in Patients with Interstitial Cystitis/Bladder Pain Syndrome.
Yu WR; Jiang YH; Jhang JF; Kuo HC
Biomedicines; 2022 May; 10(5):. PubMed ID: 35625885
[TBL] [Abstract][Full Text] [Related]
2. Can We Use Urinary Cytokine/Chemokine Analysis in Discriminating Ulcer-Type Interstitial Cystitis/Bladder Pain Syndrome?
Jiang YH; Jhang JF; Kuo HC
Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626252
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of Urinary Biomarkers for Assessing Bladder Condition and Histopathology in Patients with Interstitial Cystitis/Bladder Pain Syndrome.
Jiang YH; Jhang JF; Hsu YH; Kuo HC
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233356
[TBL] [Abstract][Full Text] [Related]
4. Urine cytokines as biomarkers for diagnosing interstitial cystitis/bladder pain syndrome and mapping its clinical characteristics.
Jiang YH; Jhang JF; Hsu YH; Ho HC; Wu YH; Kuo HC
Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1391-F1399. PubMed ID: 32281420
[TBL] [Abstract][Full Text] [Related]
5. Cystoscopic hydrodistention characteristics provide clinical and long-term prognostic features of interstitial cystitis after treatment.
Yu WR; Jhang JF; Ho HC; Jiang YH; Lee CL; Hsu YH; Kuo HC
Sci Rep; 2021 Jan; 11(1):455. PubMed ID: 33432045
[TBL] [Abstract][Full Text] [Related]
6. Urine biomarker could be a useful tool for differential diagnosis of a lower urinary tract dysfunction.
Yu WR; Jiang YH; Jhang JF; Kuo HC
Tzu Chi Med J; 2024; 36(2):110-119. PubMed ID: 38645782
[TBL] [Abstract][Full Text] [Related]
7. Use of Urinary Biomarkers in Discriminating Interstitial Cystitis/Bladder Pain Syndrome from Male Lower Urinary Tract Dysfunctions.
Yu WR; Jiang YH; Jhang JF; Kuo HC
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569430
[TBL] [Abstract][Full Text] [Related]
8. Urine Oxidative Stress Biomarkers as Novel Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome.
Jiang YH; Jhang JF; Ho HC; Chiou DY; Kuo HC
Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35885006
[TBL] [Abstract][Full Text] [Related]
9. Temporally complex inflammatory networks in an animal model reveal signatures for interstitial cystitis and bladder pain syndrome phenotype.
Shah AM; Vodovotz Y; Yoshimura N; Chermansky CJ; Fitzgerald J; Tyagi P
Neurourol Urodyn; 2023 Nov; 42(8):1839-1848. PubMed ID: 37587846
[TBL] [Abstract][Full Text] [Related]
10. Cystoscopic characteristic findings of interstitial cystitis and clinical implications.
Yu WR; Jiang YH; Jhang JF; Kuo HC
Tzu Chi Med J; 2024; 36(1):30-37. PubMed ID: 38406570
[TBL] [Abstract][Full Text] [Related]
11. Urinary Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome and Its Impact on Therapeutic Outcome.
Lin HY; Lu JH; Chuang SM; Chueh KS; Juan TJ; Liu YC; Juan YS
Diagnostics (Basel); 2021 Dec; 12(1):. PubMed ID: 35054241
[TBL] [Abstract][Full Text] [Related]
12. Sensory Receptor, Inflammatory, and Apoptotic Protein Expression in the Bladder Urothelium of Patients with Different Subtypes of Interstitial Cystitis/Bladder Pain Syndrome.
Jiang YH; Jhang JF; Birder LA; Kuo HC
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614264
[TBL] [Abstract][Full Text] [Related]
13. Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment.
Liu HT; Tyagi P; Chancellor MB; Kuo HC
BJU Int; 2009 Nov; 104(10):1476-81. PubMed ID: 19522864
[TBL] [Abstract][Full Text] [Related]
14. Repeated intravesical onabotulinumtoxinA injections are effective in treatment of refractory interstitial cystitis/bladder pain syndrome.
Kuo HC
Int J Clin Pract; 2013 May; 67(5):427-34. PubMed ID: 23574103
[TBL] [Abstract][Full Text] [Related]
15. Clinical presentation, videourodynamic characteristics, and treatment outcome in men with interstitial cystitis-like lower urinary tract symptoms.
Yu WR; Chang WC; Kuo HC
Int Urol Nephrol; 2022 Sep; 54(9):2157-2165. PubMed ID: 35804206
[TBL] [Abstract][Full Text] [Related]
16. Autonomic response during bladder hydrodistention reflects the severity of symptoms in patients with bladder pain syndrome/interstitial cystitis.
Kim SW; Son HS; Troya IS; Kim JY; Kim MJ; Fraser MO; Kim JH
Neurourol Urodyn; 2017 Mar; 36(3):677-682. PubMed ID: 27028369
[TBL] [Abstract][Full Text] [Related]
17. Potential Urine and Serum Biomarkers in Patients with Bladder Pain Syndrome/Interstitial Cystitis.
Wang L; Gao J; Zheng S; Wang Z; Zheng S; Luo Z
Arch Esp Urol; 2024 May; 77(4):353-358. PubMed ID: 38840277
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of bladder corticotropin-releasing hormone receptor in the pathogenesis of human interstitial cystitis/bladder pain syndrome.
Jhang JF; Birder LA; Jiang YH; Hsu YH; Ho HC; Kuo HC
Sci Rep; 2019 Dec; 9(1):19169. PubMed ID: 31844086
[TBL] [Abstract][Full Text] [Related]
19. Urinary ATP may be a biomarker of interstitial cystitis/bladder pain syndrome and its severity.
Wu Y; He Y; Qi J; Wang S; Wang Z
Biomol Biomed; 2024 Jan; 24(1):170-175. PubMed ID: 37819233
[TBL] [Abstract][Full Text] [Related]
20. Urinary Oxidative Stress Biomarker Levels Might Be Useful in Identifying Functional Bladder Disorders in Women with Frequency and Urgency Syndrome.
Jiang YH; Jhang JF; Kuo HC
J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]